The retinoblastoma tumor suppressor gene RB1 is more commonly loss in metastatic and antiandrogen resistant prostate cancer (74% of cases) and NEPC (90% of cases) [71] than it is in primary tumors (34% of cases) [72]. The gene discussed is RB1; the disease is prostate cancer.